What’s New and Updates/Changes

New Section: Monitoring Patients Who Are Starting HCV Treatment, Are On Treatment, Or Have Completed Therapy
Wednesday, September 24, 2014

The newest section of the AASLD/IDSA/IAS-USA hepatitis C Guidance, Monitoring Patients Who Are Starting HCV Treatment, Are On Treatment, Or Have Completed Therapy, is now available. Click here to access this section.

Updated Statement on Drug-drug Interactions
Tuesday, September 2, 2014

Simeprevir concentration is increased by approximately 6-fold when coadministered with cyclosporine (in combination with daclatasvir [an investigational drug] and RBV). Coadministration of simeprevir with cyclosporine is not recommended. For more information see Unique Patient Populations.

New Section: When and In Whom to Initiate HCV Therapy
Monday, August 11, 2014

We are pleased to introduce the newest section of the Guidance, When and in Whom to Initiate HCV Therapy. Successful hepatitis C treatment results in sustained virologic response (SVR), which is tantamount to virologic cure; virologic cure is expected to benefit chronically infected persons.

Official Press Release - When and In Whom to Initiate HCV Therapy
Monday, August 11, 2014
How to Cite and Request Permission to Reprint or Use Content in the Guidance
Tuesday, July 1, 2014

How to cite the Guidance in papers

The website as a whole.
AASLD-IDSA. Recommendations for testing, managing, and treating hepatitis C. http://www.hcvguidelines.org. $$$Insert date accessed here$$$.

A section or specific page on the website.
For example, if citing the HCV Testing and Linkage to Care section:
AASLD-IDSA. HCV testing and linkage to care. Recommendations for testing, managing, and treating hepatitis C. http://www.hcvguidelines.org/full-report/hcv-testing-and-linkage-care. $$$Insert date accessed here$$$.

How to request permission to reprint or use content in the Guidance

Copyright Clearance Center can process your request for permissions to reprint or reuse the Hepatitis C Guidance content.

With copyright.com, you can quickly and easily secure the permissions you want.

Simply follow these steps to get started:

  • Visit copyright.com and enter the title, "Recommendations for Testing, Managing, and Treating Hepatitis C" or CCC system ID: 451238344 and hit "Go"
  • After finding the GUIDANCE, choose “Pay-Per-Use Options”
  • Enter the publication year of the content you’d like to reuse
  • Scroll down the list to find the type of reuse you want to request
  • Select the corresponding bubble and click “Price & Order”
  • Fill out any required information and follow the prompts to acquire the proper permissions to reuse the content that you’d like

For questions about using the service on copyright.com, please contact:
Copyright Clearance Center
222 Rosewood Drive
Danvers, MA 01923
Phone: +1-(978) 750-8400
Fax: +1-(978) 750-4470

Additional requests can be sent directly to info@copyright.com.

About Copyright Clearance Center
Copyright Clearance Center, the rights licensing expert, is a global rights broker for the world’s most sought-after books, journals, blogs, movies, and more.  Founded in 1978 as a not-for-profit organization, CCC provides smart solutions that simplify the access and licensing of content that lets businesses and academic institutions quickly get permission to share copyright-protected materials, while compensating publishers and creators for the use of their works. We make copyright work. For more information, visit www.copyright.com.

Pages